CN Patent

CN111971035A — 生酮饮食相容的芬氟拉明制剂

Assigned to Zogenix International Ltd · Expires 2020-11-20 · 5y expired

What this patent protects

一种治疗被诊断患有癫痫亚型的患者的癫痫亚型、例如德拉韦综合征的症状的方法，所述方法通过在足以降低或完全消除患者的癫痫发作的时间段内，将有效剂量的芬氟拉明制剂与生酮饮食组合给药于所述患者。还提供了可用于实施所述方法的实施方案的组合物和试剂盒。

USPTO Abstract

一种治疗被诊断患有癫痫亚型的患者的癫痫亚型、例如德拉韦综合征的症状的方法，所述方法通过在足以降低或完全消除患者的癫痫发作的时间段内，将有效剂量的芬氟拉明制剂与生酮饮食组合给药于所述患者。还提供了可用于实施所述方法的实施方案的组合物和试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN111971035A
Jurisdiction
CN
Classification
—
Expires
2020-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Zogenix International Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.